Contact Us
- 0904.634.288, 024.8888.4288
- [email protected]
- Facebook Fanpage: http://fb.com/dauthau.info
- Messenger: http://m.me/dauthau.info
Contact Us
| No | Medicine code | Active ingredient name | Technical criteria group | Concentration or content | How to use | Dosage form | Unit | Quantity | Feature |
|---|---|---|---|---|---|---|---|---|---|
1 |
TV.L2.01 |
Desloratadin |
Group 4 |
2.5mg/5ml; 50ml |
Drink |
Oral solution |
Bottle |
1.000 |
|
2 |
TV.L2.02 |
Omeprazol |
Group 4 |
20mg |
Drink |
Tablet |
Tablet |
5.000 |
|
3 |
TV.L2.03 |
Triclabendazol |
Group 5 |
250mg |
Drink |
Tablet |
Tablet |
1.300 |
|
4 |
TV.L2.04 |
Lysine + Minerals + Vitamins |
Group 4 |
Vitamin A (Retinol palmitate) 500IU; Vitamin D3 (Cholecalciferol) 100IU; Vitamin B1 (Thiamine hydrochloride) 2.5mg; Vitamin B2 (Riboflavin) 2mg; Vitamin PP (Nicotinamide) 8mg; Vitamin B6 (Pyridoxine hydrochloride) 2mg; Vitamin B12 (Cyanocobalamin) 5.2 µg (mcg); Iron (II) sulfate 15mg; Calcium glycerophosphate 8mg; Magnesium gluconate 5mg; Lysine hydrochloride 30mg |
Drink |
Tablet |
Tablet |
90.000 |
|
5 |
TV.L2.05 |
Desogestrel + ethinyletradiol |
Group 5 |
0.15mg + 0.03mg |
Drink |
Tablet |
Tablet |
2.000 |
|
6 |
TV.L2.06 |
Tranexamic acid |
Group 5 |
500mg |
Drink |
Tablet |
Tablet |
40.000 |
|
7 |
TV.L2.07 |
Vitamin E |
Group 2 |
400mg |
Drink |
Tablet |
Tablet |
1.000 |
|
8 |
TV.L2.08 |
Each vaccine (0.5 ml) contains 25mcg per type of 23 types of polysaccharide serum of Danish pneumococcal: 1, 2, 3, 4, 5, 6b, 7f, 8, 9n, 9v, 10A, 11A, 12F, 14, 17F, 18C, 19A, 19F, 19F, 20F, 22F, 23F, 33F |
Group 1 |
Each vaccine (0.5 ml) contains 25mcg per type of 23 types of polysaccharide serum of Danish pneumococcal: 1, 2, 3, 4, 5, 6b, 7f, 8, 9n, 9v, 10A, 11A, 12F, 14, 17F, 18C, 19A, 19F, 19F, 20F, 22F, 23F, 33F |
Intramuscularly |
Injection |
Dose |
200 |
|
9 |
TV.L2.09 |
Purified surface antigen of influenza virus of strains: A/H1N1; strain A/H3N2; strain B |
Group 4 |
Each dose of 0.5 ml contains purified surface antigens of influenza viruses of the following strains: A/H1N1 strain: 15mcg HA; A/H3N2 strain: 15mcg HA; Strain B: 15mcg HA |
Inject |
Injection solution |
Dose |
500 |
|
10 |
TV.L2.10 |
Prefilled syringe with 1 dose of 0.5ml vaccine (fragment, inactivated): A/Missouri/11/2025 (H1N1)pdm09 - using equivalent strain (A/Switzerland/6849/2025, IVR-278) 15mcg HA; A/Singapore/GP20238/2024 (H3N2) - use equivalent strain (A/Singapore/GP20238/2024, IVR-277) 15mcg HA; B/Austria/1359417/2021- used equivalent strain (B/Michigan/01/2021, wild strain) 15mcg HA |
Group 1 |
Prefilled syringe with 1 dose of 0.5ml vaccine (fragment, inactivated): A/Missouri/11/2025 (H1N1)pdm09 - using equivalent strain (A/Switzerland/6849/2025, IVR-278) 15mcg HA; A/Singapore/GP20238/2024 (H3N2) - use equivalent strain (A/Singapore/GP20238/2024, IVR-277) 15mcg HA; B/Austria/1359417/2021- used equivalent strain (B/Michigan/01/2021, wild strain) 15mcg HA |
Inject |
Injection |
Box |
2.000 |
|
11 |
TV.L2.11 |
Type A (H1N1) influenza virus antigen; Type A (H3N2) influenza virus antigen; Type B influenza virus antigen |
Group 2 |
Each 0.5 ml dose contains: Type A (H1N1) influenza virus antigen 15 µg Type A (H3N2) influenza virus antigen 15 µg Type B influenza virus antigen 15 µg |
Inject |
Injection |
Dose |
2.000 |
|
12 |
TV.L2.12 |
A/Guangdong-Maonan/SWL1536/2019 (H1NA)pdm09-like strain (A/Guangdong-Maonan/SWL1536/2019, CNIC-1909); A/Hong Kong/2671/2019 (H3N2)-like strain (A/Hong Kong/2671/2019, IVR-208); B/Washington/02/2019-like strain (B/Washington/02/2019, wild type) |
Group 1 |
Each 0.5 ml of vaccine contains: A/Guangdong-Maonan/SWL1536/2019 (H1NA)pdm09-like strain (A/Guangdong-Maonan/SWL1536/2019, CNIC-1909) 15mcg heamagglutinin; A/Hong Kong/2671/2019 (H3N2)-like strain (A/Hong Kong/2671/2019, IVR-208) 15mcg heamagglutinin; B/Washington/02/2019-like strain (B/Washington/02/2019, wild type) 15mcg heamagglutinin |
Inject |
Injection |
Box |
2.000 |
|
13 |
TV.L2.13 |
Japanese encephalitis virus, pure (SA 14-14-2) 3µg/0.5ml |
Group 5 |
Japanese encephalitis virus, pure (SA 14-14-2) 3µg/0.5ml |
Inject |
Injection |
Jar |
200 |
|
14 |
TV.L2.14 |
Japanese encephalitis virus, pure (SA 14-14-2) 6 mcg/0.5ml |
Group 5 |
Japanese encephalitis virus, pure (SA 14-14-2) 6 mcg/0.5ml |
Inject |
Injection |
Jar |
100 |
|
15 |
TV.L2.15 |
Polysaccharide Polyribosulribitolphosphate (PRP) plus combination with tetanus detoxification |
Group 5 |
10 mcg PRP plus with (20.8-31.25 mcg) Tetetanic detoxification/0.5 ml |
Intramuscularly |
Injection solution |
Jar |
200 |
Downloading files directly on the new Public Procurement System requires a computer using Windows operating system and installing Client Agent software (Linux and MacOS operating systems cannot install Client software yet). Therefore, to be able to download files on smartphones, tablets or computers using operating systems other than Windows, you need to use DauThau.info software to download files.
To download, please Login or Register
Select columns to display
If you are still not our member, please sign up.You can use your account on DauThau.info to log in to Dauthau.Net, and vice versa!
Only 5 minutes and absolutely free! Your account can be use on all over our ecosystem, including DauThau.info and DauThau.Net.
Detailed instructions on how to deposit money and redeem points on DauThau.info
When does contract negotiation fail?
[VIDEO] Guide for bid solicitors to Extend the Bid Submission Deadline
[VIDEO] Guide to Evaluating Bid Documents on the New National Bidding Network System
[VIDEO] Guide to Posting Tender Notices for PPP Projects
[VIDEO] Guide to Posting Prequalification Notices for PPP Projects
[VIDEO] Guide to Responding to Clarification Requests for e-HSMST (E-Prequalification Invitation Documents) of PPP Projects on the New National Bidding Network System
[VIDEO] Guide to Uploading the Shortlist for PPP Projects
Similar goods purchased by Investor Trung tâm kiểm soát Bệnh tật tỉnh Nghệ an:
No similar goods purchased by the Investor were found.
Similar goods purchased by other Investor excluding Trung tâm kiểm soát Bệnh tật tỉnh Nghệ an:
No similar goods have been found that other Investor have purchased.
Similar goods for which the bidding results of the Ministry of Health have been announced:
No similar goods have been found in the bidding results of the Ministry of Health.